Edwin Torr
Direktor/Vorstandsmitglied bei ANIMALCARE GROUP PLC
Vermögen: 312 156 $ am 30.04.2024
Aktive Positionen von Edwin Torr
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ANIMALCARE GROUP PLC | Direktor/Vorstandsmitglied | 13.07.2017 | - |
Independent Dir/Board Member | 13.07.2017 | - | |
INTERVACC AB | Direktor/Vorstandsmitglied | 01.03.2020 | - |
Karriereverlauf von Edwin Torr
Ehemalige bekannte Positionen von Edwin Torr
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
DECHRA PHARMACEUTICALS | Direktor/Vorstandsmitglied | 01.09.2000 | 01.01.2013 |
Corporate Officer/Principal | 01.08.2012 | 01.01.2014 | |
Dechra Veterinary Products Ltd.
Dechra Veterinary Products Ltd. Pharmaceuticals: MajorHealth Technology Dechra Veterinary Products Ltd. engages in the development of branded pharmaceuticals for companion animals. The company is headquartered in Shrewsbury, the United Kingdom. | Vorstandsvorsitzender | 01.05.1997 | 01.09.2000 |
AGRIMIN LIMITED | Vorsitzender | - | - |
Statistik
International
Vereinigtes Königreich | 4 |
Schweden | 2 |
Australien | 2 |
Operativ
Director/Board Member | 3 |
Corporate Officer/Principal | 1 |
Chief Executive Officer | 1 |
Sektoral
Health Technology | 5 |
Non-Energy Minerals | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
ANIMALCARE GROUP PLC | Health Technology |
INTERVACC AB | Health Technology |
AGRIMIN LIMITED | Non-Energy Minerals |
Private Unternehmen | 2 |
---|---|
Dechra Pharmaceuticals Plc
Dechra Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Dechra Pharmaceuticals Ltd. is a holding company, which engages in the veterinary pharmaceuticals and related products business. It operates through the following segments: European Pharmaceuticals; North American Pharmaceuticals; and Pharmaceuticals Research and Development. The European Pharmaceuticals segment markets and sells licensed pharmaceuticals and specialist pet foods to the veterinary profession in Europe. The North American Pharmaceuticals segment focuses on the sale of a range of endocrine, ophthalmic, dermatological, and equine products in North America. The Pharmaceuticals Research and Development segment develops and licenses Dechra's own branded veterinary product portfolio of novel and generic pharmaceuticals and specialist pet diets. The company was founded in 1819 and is headquartered in Northwich, the United Kingdom. | Health Technology |
Dechra Veterinary Products Ltd.
Dechra Veterinary Products Ltd. Pharmaceuticals: MajorHealth Technology Dechra Veterinary Products Ltd. engages in the development of branded pharmaceuticals for companion animals. The company is headquartered in Shrewsbury, the United Kingdom. | Health Technology |
- Börse
- Insiders
- Edwin Torr
- Erfahrung